Researchers at Moffitt Cancer Center, working with colleagues at The University of Arizona and Arizona State University, have developed a new combination agent approach targeting tumor receptors based on their variety of cell surface proteins. The approach, which was tested in pancreatic cancers and melanoma modeled in tumor-bearing mice, opens the possibility of developing new multivalent agents that can target unique and multiple receptor combinations in tumor cells. This is a significant improvement over current single-target strategies.
Recent PostsMonday, April 17, 2017
A University of Central Florida student is taking the lead on propelling his professor’s energy-storage invention into the marketplace and, with the help of several of the university’s innovation support programs, is getting noticed. ..Read More ⇒Friday, April 14, 2017
USF's Sami Noujaim's research aims to understand how normal and abnormal electrical impulses are generated in the heart and finding more effective drugs to treat atrial fibrillation, the most common irregular heart rhythm. ..Read More ⇒Friday, April 14, 2017
The FDA approved the drug, sold as Ocrevus, two weeks ago. The approval comes after a series of clinical trials across the nation, including at the University of South Florida’s Multiple Sclerosis Center in Tampa. ..Read More ⇒Wednesday, April 12, 2017
UCF’s first patent application was filed 30 years ago this month. Since this first patent filing, UCF has accumulated 925 issued patents. But the institution has bigger ambitions and aspires to be a top-tier research university within the next decade. ..Read More ⇒Wednesday, April 12, 2017
Bacteria are everywhere. And despite widespread belief, not all bacteria are “bad.” However, to combat those that can cause health issues for humans, there has been an over-reliance on the use of antibiotics – so much so, that many of them are now proving ineffective due to bacteria developing increased resistance to them. ..Read More ⇒
TagsNova Southeastern Univ. sustainability Torrey Pines Institute accolades BioFlorida Banyan Biomarkers commercialization business economy robotics conference / event neuroscience Florida Gulf Coast Univ. AxoGen sciences aerospace accreditation University of West Florida awards nanotechnology clean energy technology Mayo Clinic Florida State University HIV/AIDS research policy energy aging gender GrowFL bioscience Scripps Research Institute health children University of North Florida AGTC VGTI grants Draper health care stem cell physics medical IHMC Florida Atlantic University biomedical FAMU society/culture Jackson Lab astronomy ICFO ecology Florida International Univ. University of Miami environment Univeristy of South Florida animals education marine materials science consumers Sanford-Burnham Nanotheraputics FL Institute for Commercialization of Public Research research green technology Florida Power & Light University of Florida University of Central Florida computer science Max Planck Florida Institute of Technology cancer Florida Trend agriculture innovation engineering photonics Enterprise Florida accounting policy Embry-Riddle Moffitt Cancer Center magnets biotechnology Florida Hospital partnerships biochemistry